Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
Yu-Qing Tan,1,2 Heng-Wen Chen,1,* Jun Li1,* 1Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, People’s Republic of China; 2Graduate School of Beijing University of Chinese Medicine, Beijing University of Chinese Medicine,...
Saved in:
Main Authors: | Tan YQ (Author), Chen HW (Author), Li J (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review on the protective mechanism of astragaloside IV against cardiovascular diseases
by: Chunkun Yang, et al.
Published: (2023) -
Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
by: Tan J, et al.
Published: (2023) -
Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
by: Wei Liu, et al.
Published: (2019) -
Effects of Astragaloside IV on heart failure in rats
by: Xu Weiren, et al.
Published: (2009) -
Astragaloside IV, as a potential anticancer agent
by: Dongqin Xia, et al.
Published: (2023)